Learn More
Invitrogen™ ADAMTS13 Monoclonal Antibody (20A5)

Description
The monoclonal antibody 20A5 recognizes human ADAMTS-13, A Disintegrin And Metalloprotease with ThromboSpondin type 1 domain 13.
Specifications
Specifications
| Antigen | ADAMTS13 |
| Applications | Inhibition Assays, Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Clone | 20A5 |
| Concentration | 100 μg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide |
| Gene | ADAMTS13 |
| Gene Accession No. | Q76LX8 |
| Gene Alias | a disintegrin and metalloproteinase; A disintegrin and metalloproteinase with thrombospondin motifs 13; A disintegrin and metalloproteinase with thrombospondin motifs 13-like; a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 13; ADAM; ADAM metallopeptidase with thrombospondin type 1 motif 13; ADAM metallopeptidase with thrombospondin type 1 motif, 13; ADAMs; ADAM-TS 13; ADAMTS13; ADAM-TS13; ADAMTS-13; C9orf8; Gm710; LOC102554393; metalloendopeptidases; UNQ6102/PRO20085; von Willebrand factor-cleaving protease; vWF-cleaving protease; VWFCP; vWF-CP; vWF-CP mRNA for von Willebrand factor-cleaving |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.